ArticleCureus2026
Aesthetic Chin Retrusion Enhancement With Non-animal Stabilized Hyaluronic Acid-High Density (NASHA-HD™) Filler.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChin projection is a critical component of lower face aesthetics, influencing facial balance, youthfulness, and sexual dimorphism.
methodsThis retrospective case series provides short-term, real-world observations on the use of Non-animal Stabilized Hyaluronic Acid - High Density (NASHA-HD™) injectable for chin augmentation as part of a combined lower-face hyaluronic acid (HA) filler treatment approach. Each patient received 1 mL of High-Animal Stabilized Hyaluronic Acid (HASHA™) administered as supraperiosteal boluses in the chin, distributed according to the patient's needs. For a comprehensive facial approach, complementary injections of HA fillers based on Optimal Balance Technology (OBT
resultsResults demonstrated high patient satisfaction, natural aesthetic outcomes, a natural look on the chin, and a favorable safety profile with only mild and transient adverse events. Independent Global Aesthetic Improvement Scale (iGAIS)-physician assessment demonstrated global aesthetic improvement and enhanced facial proportionality in most patients. This holistic approach achieved satisfactory projection and contour enhancement using low product volumes.
conclusionsThis article underscores the importance of using high G' fillers for structural support, and flexible fillers for dynamic zones, particularly in the diverse population, which presents a wide range of facial morphologies requiring personalized aesthetic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.